Mary E Dillhoff, MD
Academic Title: Professor in the College of Medicine
Research Program: Translational Therapeutics
About Me
More info forI’m a surgical oncologist with a specialty in diagnosing and treating patients with tumors of the pancreas, liver, bile duct and stomach. Patient care at the OSUCCC – James starts with an evaluation by our multidisciplinary team to determine the best therapy, targeted treatments and possible clinical trials that may benefit the patient. I use robotic surgery and minimally invasive techniques when appropriate to improve recovery time and decrease pain after surgery. The OSUCCC – James started the robotic whipple program in 2017 and has quickly became a national leader in robotic whipple operations and robotic hepatobiliary surgery. It has already become one of the nation’s highest-volume robotic programs, due in large part to our experienced and excellent team. This robotic technique can reduce blood loss and perhaps accelerate recovery. My passion is to help patients through their illness by giving them the very best clinical care while also researching these diseases to better treat or prevent them in the future. As a member of the Translational Therapeutics Program at the OSUCCC – James, I’m currently investigating circulating tumor DNA in patients with pancreatic cancer and cystic lesions of the pancreas. We also have open trials for patients with hepatobiliary cancers and work hard to enroll patients that benefit from these trials. My passion for taking care of patients has led me to have the honor of being rated in the top 10 percent of physicians in the nation for patient satisfaction in 2016, 2017 and 2018. It’s a privilege and honor to work for The James. Collaborating with this world-class team allows me to give patients the very best care, and because of our status as a National Cancer Institute (NCI)-designated comprehensive cancer center, we’re able to enroll patients in clinical trials and offer them the most advanced therapies. It’s gratifying to know we’ve helped a cancer patient through a big part of their treatment. It’s also an honor to be there in their time of need.
Clinical Expertise
More info for- Stomach Cancers
- Small Intestine Cancer
- Liver Cancers
- Pancreatic Cancers
- Gallbladder Cancers
- Pancreatic Cyst
- Gastrointestinal Cancers
- Minimally Invasive Surgical Procedures
- Robotics
Research Interests
More info for- Neoplasms
- DNA Damage
- Neoplastic Processes
- Pancreatic Neoplasms
- Neoplasm Metastasis
- Pancreatitis, Chronic
- Neuroendocrine Tumors
Where I See Patients
More info forEducation & Training
More info forFellowship - Surgical Oncology
- Memorial Sloan-Kettering Cancer Center
1275 York Ave, New York, NY
Internship - Surgery (General Surgery)
- Ohio State University Wexner Medical Center
700 Ackerman Rd, Columbus, OH
Residency - Surgery (General Surgery)
- Ohio State University Wexner Medical Center
700 Ackerman Rd, Columbus, OH
Medical School
- University of Cincinnati College of Medicine
231 Albert Sabin Way, Cincinnati, OH
- Memorial Sloan-Kettering Cancer Center
Academic Office & Contact Information
More info forAcademic Office:
410 W 10th Ave
Columbus, Ohio 43210-1228Phone:
614-293-6408Email:
dillhoff.7@osu.eduReviews
More info forPatient Satisfaction Review
The overall patient satisfaction rating is an average of all patient responses to the five questions gathered from the Outpatient Oncology survey, developed by Press Ganey Associates for use in oncology clinics across the country. On behalf of The James, Press Ganey administers the survey to patients who see our providers in an outpatient clinic office. For additional information about the patient satisfaction survey, please visit our
Patient Satisfaction Survey page The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of The James.
Videos
More info forPublications
More info forAugust 30, 2024Trans-arterial embolization versus chemoembolization for neuroendocrine liver metastases: a propensity matched analysis.
Ruff SM, Chang JY, Xu M, Ejaz AM, Dillhoff M, Pawlik TM, Makary MS, Rikabi A, Sukrithan V, Konda B, Cloyd JM
HPB (Oxford)
August 21, 2024Trends in the Use of Observation for Small Nonfunctional Pancreatic Neuroendocrine Tumors.
Ruff SM, Dillhoff M, Tsai S, Pawlik TM, Sukrithan V, Konda B, Cloyd JM
JAMA Surg
August 20, 2024Mature MUC5AC Expression in Resected Pancreatic Ductal Adenocarcinoma Predicts Treatment Response and Outcomes.
Manne A, Esnakula A, Sheel A, Sara A, Manne U, Paluri RK, He K, Yang W, Sohal D, Kasi A, Noonan AM, Mittra A, Hays J, Roychowdhury S, Malalur P, Rahman S, Jin N, Cloyd JM, Tsai S, Ejaz A, Pitter K, Miller E, Thanikachalam K, Dillhoff M, Yu L
Int J Mol Sci
August 15, 2024Association of county-level provider density with hepatobiliary cancer incidence and mortality.
Khan MMM, Munir MM, Thammachack R, Endo Y, Altaf A, Woldesenbet S, Rashid Z, Khalil M, Dillhoff M, Tsai S, Pawlik TM
World J Surg
July 24, 2024Gender-Based Variations in Medicare Reimbursements Among Different Surgical Subspecialties.
Munir MM, Dillhoff M, Tsai S, Collins C, Dedhia P, Pawlik TM
JAMA Surg
July 1, 2024Minimally Invasive Techniques for Gastrectomy.
Ruff SM, Dillhoff ME
Surg Oncol Clin N Am
June 17, 2024Association between quality metric adherence and overall survival among patients undergoing resection of pancreatic ductal adenocarcinoma.
Munir MM, Rashid Z, Endo Y, Dillhoff M, Tsai S, Pawlik TM
Surgery
June 11, 2024Postoperative Outcomes Among Patients Undergoing Cancer Surgery: United States versus International Medical Graduates.
Khan MMM, Munir MM, Woldesenbet S, Khalil M, Endo Y, Katayama E, Tsilimigras D, Rashid Z, Altaf A, Dillhoff M, Tsai S, Pawlik TM
Ann Surg
June 10, 2024ASO Visual Abstract: Long-Term Health Outcomes of New Persistent Opioid Use After Gastrointestinal Cancer Surgery.
Khalil M, Woldesenbet S, Munir MM, Khan MMM, Rashid Z, Altaf A, Katayama E, Endo Y, Dillhoff M, Tsai S, Pawlik TM
Ann Surg Oncol
May 27, 2024Impact of early primary care physician follow-up on hospital readmission following gastrointestinal cancer surgery.
Khalil M, Woldesenbet S, Munir MM, Khan MMM, Rashid Z, Altaf A, Katayama E, Dillhoff M, Tsai S, Pawlik TM
J Surg Oncol
May 22, 2024Textbook oncologic outcomes among patients undergoing laparoscopic, robotic and open surgery for intrahepatic and perihilar cholangiocarcinoma.
Munir MM, Dillhoff M, Tsai S, Pawlik TM
HPB (Oxford)
May 18, 2024Long-term Health Outcomes of New Persistent Opioid Use After Gastrointestinal Cancer Surgery.
Khalil M, Woldesenbet S, Munir MM, Khan MMM, Rashid Z, Altaf A, Katayama E, Endo Y, Dillhoff M, Tsai S, Pawlik TM
Ann Surg Oncol
May 17, 2024Healthcare utilization and expenditures among patients with venous thromboembolism following gastrointestinal cancer surgery.
Khalil M, Woldesenbet S, Munir MM, Khan MMM, Rashid Z, Altaf A, Katayama E, Endo Y, Dillhoff M, Tsai S, Pawlik TM
J Gastrointest Surg
May 17, 2024Association of preoperative cholangitis with outcomes and expenditures among patients undergoing pancreaticoduodenectomy.
Rashid Z, Munir MM, Woldesenbet S, Khalil M, Katayama E, Khan MMM, Endo Y, Altaf A, Tsai S, Dillhoff M, Pawlik TM
J Gastrointest Surg
May 15, 2024ASO Visual Abstract: Association of Hospital Market Competition with Outcomes of Complex Cancer Surgery.
Munir MM, Woldesenbet S, Endo Y, Dillhoff M, Tsai S, Pawlik TM
Ann Surg Oncol
April 18, 2024Association of Hospital Market Competition with Outcomes of Complex Cancer Surgery.
Munir MM, Woldesenbet S, Endo Y, Dillhoff M, Tsai S, Pawlik TM
Ann Surg Oncol
April 12, 2024Cannabis use disorder and perioperative outcomes following complex cancer surgery.
Munir MM, Woldesenbet S, Endo Y, Dillhoff M, Pawlik TM
J Surg Oncol
April 1, 2024Care fragmentation in hepatopancreatic surgery and postoperative outcomes.
Rashid Z, Munir MM, Woldesenbet S, Tsilimigras DI, Khalil M, Khan MMM, Resende V, Dillhoff M, Ejaz A, Pawlik TM
Surgery
March 28, 2024Disparities in Clinical Trial Enrollment among Patients with Gastrointestinal Cancer Relative to Minority-Serving and Safety Netting Hospitals.
Mehdi Khan MM, Munir MM, Woldesenbet S, Khalil M, Endo Y, Katayama E, Altaf A, Dillhoff M, Obeng-Gyasi S, Pawlik TM
J Gastrointest Surg
March 11, 2024Survival disparities in rural versus urban patients with pancreatic neuroendocrine tumor: A multi-institutional study from the US neuroendocrine tumor study group.
Mirza MB, Baechle JJ, Marincola Smith P, Dillhoff M, Poultsides G, Rocha FG, Cho CS, Winslow ER, Fields RC, Maithel SK, Idrees K
Am J Surg
March 4, 2024Surgical outcomes and healthcare expenditures among patients with dementia undergoing major surgery.
Khalil M, Woldesenbet S, Munir MM, Katayama E, Mehdi Khan MM, Altaf A, Rashid Z, Endo Y, Dillhoff M, Tsai S, Pawlik TM
World J Surg
February 29, 2024Effect of Behavioral Health Disorders on Surgical Outcomes in Cancer Patients.
Katayama ES, Woldesenbet S, Munir MM, Endo Y, Rawicz-Pruszynski K, Khan MMM, Tsilimigras D, Dillhoff M, Cloyd J, Pawlik TM
J Am Coll Surg
February 10, 2024ASO Visual Abstract: Variation in Hospital Mortality After Complex Cancer Surgery-Patient, Volume, Hospital, or Social Determinants?
Munir MM, Woldesenbet S, Endo Y, Dillhoff M, Cloyd J, Ejaz A, Pawlik TM
Ann Surg Oncol
January 11, 2024Association of Racial and Economic Privilege on Postoperative Outcomes Among Medicare Beneficiaries.
Munir MM, Lima HA, Endo Y, Moazzam Z, Woldesenbet S, Azap L, Katayama E, Dilhoff M, Cloyd J, Ejaz A, Pawlik TM
J Surg Res
January 11, 2024Intracystic injection of large surface area microparticle paclitaxel for chemoablation of intraductal papillary mucinous neoplasms: Insights from an expanded access protocol.
Krishna SG, Ardeshna DR, Shah ZK, Hart PA, Culp S, Jones D, Chen W, Papachristou GI, Han S, Lee PJ, Shah H, Pawlik TM, Dillhoff M, Manilchuk A, Cloyd J JM, Ejaz A, Fry M, Noonan AM
Pancreatology
January 9, 2024Variation in Hospital Mortality After Complex Cancer Surgery: Patient, Volume, Hospital or Social Determinants?
Munir MM, Woldesenbet S, Endo Y, Dillhoff M, Cloyd J, Ejaz A, Pawlik TM
Ann Surg Oncol
January 1, 2024Online artificial intelligence platforms and their applicability to gastrointestinal surgical operations.
Munir MM, Endo Y, Ejaz A, Dillhoff M, Cloyd JM, Pawlik TM
J Gastrointest Surg
December 27, 2023Association between social determinants of health and delayed postoperative adjuvant therapy among patients undergoing resection of pancreatic cancer.
Rashid Z, Munir MM, Woldesenbet S, Khan MMM, Khalil M, Endo Y, Tsilimigras DI, Dillhoff M, Ejaz A, Pawlik TM
J Surg Oncol
December 8, 2023Evaluating the caregiver experience during neoadjuvant therapy for pancreatic ductal adenocarcinoma.
Ruff SM, Stevens L, Bressler L, Khatri R, Sarna A, Ejaz AM, Dillhoff M, Pawlik TM, Rose K, Cloyd JM
J Surg Oncol
November 22, 2023Association of surgeon-patient sex concordance with postoperative outcomes following complex cancer surgery.
Khan MMM, Munir MM, Woldesenbet S, Endo Y, Rawicz-Pruszynski K, Katayama E, Ejaz A, Cloyd J, Dilhoff M, Pawlik TM
J Surg Oncol
November 8, 2023Association of County-Level Food Deserts and Food Swamps with Hepatopancreatobiliary Cancer Outcomes.
Khalil M, Munir MM, Endo Y, Woldesenbet S, Resende V, Rawicz-Pruszynski K, Khan MMM, Waqar U, Katayama E, Dilhoff M, Cloyd J, Ejaz A, Pawlik TM
J Gastrointest Surg
November 8, 2023Association of Textbook Outcome and Hospital Volume with Long-Term Survival Following Resection for Hepatocellular Carcinoma: What Matters More?
Khalil M, Tsilimigras DI, Endo Y, Khan MMM, Munir MM, Katayama E, Rashid Z, Resende V, Dillhoff M, Cloyd J, Ejaz A, Pawlik TM
J Gastrointest Surg
September 20, 2023ASO Visual Abstract: Association of Race/Ethnicity, Persistent Poverty, and Opioid Access Among Patients with Gastrointestinal Cancer Near the End of Life.
Munir MM, Woldesenbet S, Endo Y, Ejaz A, Cloyd JM, Obeng-Gyasi S, Dillhoff M, Waterman B, Gustin J, Pawlik TM
Ann Surg Oncol
September 15, 2023ASO Visual Abstract: Variations in Travel Patterns Affect Regionalization of Complex Cancer Surgery in California.
Munir MM, Endo Y, Woldesenbet S, Beane J, Mary Dillhoff , Ejaz A, Cloyd J, Pawlik TM
Ann Surg Oncol
September 4, 2023Association of Race/Ethnicity, Persistent Poverty, and Opioid Access Among Patients with Gastrointestinal Cancer Near the End of Life.
Munir MM, Woldesenbet S, Endo Y, Ejaz A, Cloyd JM, Obeng-Gyasi S, Dillhoff M, Waterman B, Gustin J, Pawlik TM
Ann Surg Oncol
September 2, 2023Variations in Travel Patterns Affect Regionalization of Complex Cancer Surgery in California.
Munir MM, Endo Y, Woldesenbet S, Beane J, Dillhoff M, Ejaz A, Cloyd J, Pawlik TM
Ann Surg Oncol
May 17, 2023ASO Visual Abstract: The Impact of Medicaid Expansion on Early-Stage Hepatocellular Carcinoma Care.
Lima HA, Endo Y, Moazzam Z, Alaimo L, Dillhoff M, Kim A, Beane J, Ejaz A, Cloyd J, Resende V, Pawlik TM
Ann Surg Oncol
May 4, 2023The Impact of Medicaid Expansion on Early-Stage Hepatocellular Carcinoma Care.
Lima HA, Endo Y, Moazzam Z, Alaimo L, Dillhoff M, Kim A, Beane J, Ejaz A, Cloyd J, Resende V, Pawlik TM
Ann Surg Oncol
April 25, 2023Disparities in Socioeconomic Factors Mediate the Impact of Racial Segregation Among Patients With Hepatopancreaticobiliary Cancer.
Munir MM, Woldesenbet S, Endo Y, Moazzam Z, Lima HA, Azap L, Katayama E, Alaimo L, Shaikh C, Dillhoff M, Cloyd J, Ejaz A, Pawlik TM
Ann Surg Oncol
April 25, 2023ASO Visual Abstract: Suicidal Ideation Among Patients with Gastrointestinal Cancer.
Katayama ES, Moazzam Z, Woldesenbet S, Lima HA, Endo Y, Azap L, Yang J, Dillhoff M, Ejaz A, Cloyd J, Pawlik TM
Ann Surg Oncol
April 25, 2023ASO Visual Abstract: Disparities in Socioeconomic Factors Mediate Impact of Racial Segregation Among Patients with Hepatopancreaticobiliary Cancer.
Munir MM, Woldesenbet S, Endo Y, Moazzam Z, Lima HA, Azap L, Katayama E, Alaimo L, Shaikh C, Dillhoff M, Cloyd J, Ejaz A, Pawlik TM
Ann Surg Oncol
April 20, 2023Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial.
D'Angelica MI, Ellis RJ, Liu JB, Brajcich BC, Gönen M, Thompson VM, Cohen ME, Seo SK, Zabor EC, Babicky ML, Bentrem DJ, Behrman SW, Bertens KA, Celinski SA, Chan CHF, Dillhoff M, Dixon MEB, Fernandez-Del Castillo C, Gholami S, House MG, Karanicolas PJ, Lavu H, Maithel SK, McAuliffe JC, Ott MJ, Reames BN, Sanford DE, Sarpel U, Scaife CL, Serrano PE, Smith T, Snyder RA, Talamonti MS, Weber SM, Yopp AC, Pitt HA, Ko CY
JAMA
April 16, 2023Suicidal Ideation Among Patients with Gastrointestinal Cancer.
Katayama ES, Moazzam Z, Woldesenbet S, Lima HA, Endo Y, Azap L, Yang J, Dillhoff M, Ejaz A, Cloyd J, Pawlik TM
Ann Surg Oncol
March 28, 2023The impact of digital inequities on gastrointestinal cancer disparities in the United States.
Fei-Zhang DJ, Moazzam Z, Ejaz A, Cloyd J, Dillhoff M, Beane J, Bentrem DJ, Pawlik TM
J Surg Oncol
March 22, 2023ASO Visual Abstract: Disparities in NCCN Guideline Compliant Care for Patients with Early-Stage Pancreatic Adenocarcinoma at Minority-Serving Versus Non-Minority-Serving Hospitals.
Lima HA, Alaimo L, Moazzam Z, Endo Y, Woldesenbet S, Katayama E, Munir MM, Shaikh C, Ruff SM, Dillhoff M, Beane J, Cloyd J, Ejaz A, Resende V, Pawlik TM
Ann Surg Oncol
March 18, 2023Mediators of county-level racial and economic privilege in cancer screening.
Munir MM, Woldesenbet S, Alaimo L, Moazzam Z, Lima HA, Endo Y, Beane J, Kim A, Dillhoff M, Cloyd J, Ejaz A, Pawlik TM
J Surg Oncol
March 10, 2023The implications of fragmented practice in hepatopancreatic surgery.
Moazzam Z, Lima HA, Endo Y, Alaimo L, Ejaz A, Dillhoff M, Cloyd J, Pawlik TM
Surgery
December 31, 2022ASO Visual Abstract: Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors.
Makris EA, Cannon JGD, Norton JA, Lopez-Aguiar AG, Dillhoff M, Beal E, Idrees K, Smith PM, Rocha FG, Kanji Z, Cho C, Beems M, Weber S, Fisher A, Krasnick BA, Fields RC, Maithel SK, Poultsides GA
Ann Surg Oncol
November 8, 2022Surgical resection rates after neoadjuvant therapy for localized pancreatic ductal adenocarcinoma: meta-analysis.
Brown ZJ, Heh V, Labiner HE, Brock GN, Ejaz A, Dillhoff M, Tsung A, Pawlik TM, Cloyd JM
Br J Surg
September 22, 2022Textbook oncologic outcomes and regionalization among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma.
Munir MM, Alaimo L, Moazzam Z, Endo Y, Lima HA, Shaikh C, Ejaz A, Beane J, Dillhoff M, Cloyd J, Pawlik TM
J Surg Oncol
June 25, 2022The Neonatal Fc Receptor Is Elevated in Monocyte-Derived Immune Cells in Pancreatic Cancer.
Thomas J, Torok MA, Agrawal K, Pfau T, Vu TT, Lyberger J, Chang H, Castillo AMM, Chen M, Remaily B, Kim K, Xie Z, Dillhoff ME, Kulp SK, Behbehani GK, Cruz-Monserrate Z, Ganesan LP, Owen DH, Phelps MA, Coss CC, Mace TA
Int J Mol Sci
June 15, 2022Comparing Minimally Invasive and Open Pancreaticoduodenectomy for the Treatment of Pancreatic Cancer: a Win Ratio Analysis.
Beal EW, Dalmacy D, Paro A, Hyer JM, Cloyd J, Dillhoff M, Ejaz A, Pawlik TM
J Gastrointest Surg
January 1, 2022Identification of circulating plasma ceramides as a potential sexually dimorphic biomarker of pancreatic cancer-induced cachexia.
Chakedis JM, Dillhoff ME, Schmidt CR, Rajasekera PV, Evans DC, Williams TM, Guttridge DC, Talbert EE
JCSM Rapid Commun
October 27, 2021Patterns of health care utilization among Medicare beneficiaries diagnosed with pancreatic adenocarcinoma.
Paro A, Dalmacy D, Hyer JM, Ejaz A, Cloyd J, Dillhoff M, Tsung A, Tsilimigras DI, Pawlik TM
Am J Surg
October 15, 2021Development of a MicroRNA Signature Predictive of Recurrence and Survival in Pancreatic Ductal Adenocarcinoma.
Sebastian NT, Webb A, Merrell KW, Koay EJ, Wolfe AR, Zhang L, Wilhite TJ, Elganainy D, Robb R, Chen W, Cloyd J, Dillhoff M, Tsung A, Abushahin L, Noonan A, Williams TM
Cancers (Basel)
May 4, 2021Hemoglobin A1c Is a Predictor of New Insulin Dependence After Partial Pancreatectomy: A Multi-Institutional Analysis.
Wiseman JT, Chakedis J, Beal EW, Paredes A, McElhany A, Fang A, Manilchuk A, Ellison C, Van Buren G, Pawlik TM, Schmidt CR, Fisher WE, Dillhoff M
J Gastrointest Surg
March 2, 2021Increasing neutrophil-to-lymphocyte ratio following radiation is a poor prognostic factor and directly correlates with splenic radiation dose in pancreatic cancer.
Wolfe AR, Siedow M, Nalin A, DiConstanzo D, Miller ED, Diaz DA, Arnett A, Cloyd JM, Dillhoff M, Ejaz A, Tsung A, Williams TM
Radiother Oncol
February 17, 2021Neoadjuvant therapy versus surgery first for ampullary carcinoma: A propensity score-matched analysis of the NCDB.
Guo M, Beal EW, Miller ED, Williams TM, Tsung A, Dillhoff M, Ejaz A, Pawlik TM, Cloyd JM
J Surg Oncol
February 3, 2021Women in hepato-pancreatico-biliary surgery: is there a pipeline problem?
Dillhoff M, Pawlik TM
HPB (Oxford)
January 15, 2021ASO Author Reflections: Role of Node Dissection in Pancreatic Tumor Resection.
Dillhoff M, Pawlik TM
Ann Surg Oncol
January 13, 2021Impact of cancer center accreditation on outcomes of patients undergoing resection for hepatocellular carcinoma: A SEER-Medicare analysis.
Tsilimigras DI, Hyer JM, Diaz A, Moris D, Abbas A, Dillhoff M, Cloyd JM, Ejaz A, Beane JD, Tsung A, Pawlik TM
Am J Surg
January 5, 2021Resection of Primary Gastrointestinal Neuroendocrine Tumor Among Patients with Non-Resected Metastases Is Associated with Improved Survival: A SEER-Medicare Analysis.
Tsilimigras DI, Hyer JM, Paredes AZ, Ejaz A, Cloyd JM, Beane JD, Dillhoff M, Tsung A, Pawlik TM
J Gastrointest Surg
January 3, 2021Role of Node Dissection in Pancreatic Tumor Resection.
Dillhoff M, Pawlik TM
Ann Surg Oncol
January 1, 2021Using Endoscopic Optical Coherence Tomography to Detect and Treat Early-Stage Pancreatic Cancers.
Lu L, Hu Z, Frankel W, Shen R, Chen W, Pan X, Grecula JC, Bloomston MP, Dillhoff ME
Front Oncol
December 28, 2020High Social Vulnerability and "Textbook Outcomes" after Cancer Surgery.
Hyer JM, Tsilimigras DI, Diaz A, Mirdad RS, Azap RA, Cloyd J, Dillhoff M, Ejaz A, Tsung A, Pawlik TM
J Am Coll Surg
December 3, 2020Inter-surgeon variability is associated with likelihood to undergo minimally invasive hepatectomy and postoperative mortality.
Tsilimigras DI, Hyer JM, Chen Q, Diaz A, Paredes AZ, Moris D, Dillhoff M, Cloyd JM, Beane JD, Tsung A, Ejaz A, Pawlik TM
HPB (Oxford)
November 11, 2020Assessment of hospital quality and safety standards among Medicare beneficiaries undergoing surgery for cancer.
Mehta R, Tsilimigras DI, Paredes A, Dillhoff M, Cloyd JM, Ejaz A, Tsung A, Pawlik TM
Surgery
November 10, 2020The association of Hospital Medicare beneficiary payer-mix, national quality rankings and outcomes following hepatopancreatic surgery.
Paredes AZ, Hyer JM, Tsilimigras DI, Dillhoff M, Cloyd JM, Ejaz A, Tsung A, Collins C, Pawlik TM
Am J Surg
October 27, 2020Long-term outcomes after resection of alcohol-related versus hepatitis-related hepatocellular carcinoma: A SEER-Medicare database analysis.
Mehta R, Tang Qinghe , Tsilimigras DI, Paredes A, Dillhoff M, Cloyd JM, Ejaz A, Tsung A, Spolverato G, Pawlik TM
Am J Surg
September 15, 2020The impact of individual surgeon on the likelihood of minimal invasive surgery among Medicare beneficiaries undergoing pancreatic resection.
Tsilimigras DI, Chen Q, Hyer JM, Paredes AZ, Mehta R, Dillhoff M, Cloyd JM, Ejaz A, Beane JD, Tsung A, Pawlik TM
Surgery
September 12, 2020County-Level Variation in Utilization of Surgical Resection for Early-Stage Hepatopancreatic Cancer Among Medicare Beneficiaries in the USA.
Mehta R, Tsilimigras DI, Paredes AZ, Hyer M, Dillhoff M, Cloyd JM, Ejaz A, Tsung A, Pawlik TM
J Gastrointest Surg
August 22, 2020Association of pre-existing mental illness with all-cause and cancer-specific mortality among Medicare beneficiaries with pancreatic cancer.
Paredes AZ, Hyer JM, Tsilimigras DI, Palmer E, Lustberg MB, Dillhoff ME, Cloyd JM, Tsung A, Ejaz A, Wells-Di Gregorio S, Pawlik TM
HPB (Oxford)
August 5, 2020Indications and outcomes of enucleation versus formal pancreatectomy for pancreatic neuroendocrine tumors.
Heidsma CM, Tsilimigras DI, van Dieren S, Rocha F, Abbott DE, Fields R, Smith PM, Poultsides GA, Cho C, Dillhoff M, Lopez-Aguiar AG, Kanji Z, Fisher A, Krasnick BA, Idrees K, Makris E, Beems M, van Eijck CHJ, Nieveen van Dijkum EJM, Maithel SK, Pawlik TM
HPB (Oxford)
July 7, 2020Is Patient Satisfaction Dictated by Quality of Care Among Patients Undergoing Complex Surgical Procedures for a Malignant Indication?
Mehta R, Tsilimigras DI, Paredes AZ, Dillhoff M, Cloyd JM, Ejaz A, Tsung A, Pawlik TM
Ann Surg Oncol
June 16, 2020Wide variation in inpatient opioid utilization following hepatopancreatic surgery.
Paredes AZ, Hyer JM, Tsilimigras DI, Dillhoff ME, Ejaz A, Cloyd JM, Tsung A, Pawlik TM
HPB (Oxford)
June 8, 2020Travel Patterns among Patients Undergoing Hepatic Resection in California: Does Driving Further for Care Improve Outcomes?
Diaz A, Cloyd JM, Manilchuk A, Dillhoff M, Beane J, Tsung A, Ejaz A, Pawlik TM
J Gastrointest Surg
June 1, 2020CD200 promotes immunosuppression in the pancreatic tumor microenvironment.
Choueiry F, Torok M, Shakya R, Agrawal K, Deems A, Benner B, Hinton A, Shaffer J, Blaser BW, Noonan AM, Williams TM, Dillhoff M, Conwell DL, Hart PA, Cruz-Monserrate Z, Bai XF, Carson Iii WE, Mace TA
J Immunother Cancer
May 19, 2020Comparison of lymph node evaluation and yield among patients undergoing open and minimally invasive surgery for gallbladder adenocarcinoma.
Hamad A, Cloyd JM, Dillhoff M, Manilchuk A, Pawlik TM, Tsung A, Ejaz A
Surg Endosc
May 16, 2020Neoadjuvant-modified FOLFIRINOX vs nab-paclitaxel plus gemcitabine for borderline resectable or locally advanced pancreatic cancer patients who achieved surgical resection.
Wolfe AR, Prabhakar D, Yildiz VO, Cloyd JM, Dillhoff M, Abushahin L, Alexandra Diaz D, Miller ED, Chen W, Frankel WL, Noonan A, Williams TM
Cancer Med
May 1, 2020Disparities in the Use of Neoadjuvant Therapy for Resectable Pancreatic Ductal Adenocarcinoma.
Cloyd JM, Shen C, Santry H, Bridges J, Dillhoff M, Ejaz A, Pawlik TM, Tsung A
J Natl Compr Canc Netw
April 27, 2020Correction to: Trends in the Number of Lymph Nodes Evaluated Among Patients with Pancreatic Neuroendocrine Tumors in the United States: A Multi-Institutional and National Database Analysis.
Sahara K, Tsilimigras DI, Mehta R, Moro A, Paredes AZ, Lopez-Aguiar AG, Rocha F, Kanji Z, Weber S, Fisher A, Fields RC, Krasnick BA, Idrees K, Smith PM, Poultsides GA, Makris E, Cho C, Beems M, Dillhoff M, Maithel SK, Endo I, Pawlik TM
Ann Surg Oncol
April 15, 2020Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials.
Cloyd JM, Heh V, Pawlik TM, Ejaz A, Dillhoff M, Tsung A, Williams T, Abushahin L, Bridges JFP, Santry H
J Clin Med
April 14, 2020Influence of hospital teaching status on the chance to achieve a textbook outcome after hepatopancreatic surgery for cancer among Medicare beneficiaries.
Mehta R, Paredes AZ, Tsilimigras DI, Moro A, Sahara K, Farooq A, Dillhoff M, Cloyd JM, Tsung A, Ejaz A, Pawlik TM
Surgery
Consulting and Related Relationships
More info forAt The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 09/30/2024, Dr. Dillhoff has reported no relationships with companies or entities.
Patient Comments
Dr. Dillhoff and her staff are amazing,my appointments are always efficient with little wait time . I never feel rushed and leave with answers.
Dr. Dillhoff was very professional, straight forward with the information but yet caring. We never felt rushed.
Dr. Dillhoff has always been compassionate, taking time to listen to my concerns and my story. She didn't blow me off as if what I had to say didn't matter or she was too busy. She listened and made me feel part of my care plan from the very beginning. I am blessed to have her as my surgeon. She's a great surgeon and has a great team working with her.
Clear and honest comments about next steps.
Dr. Dillhoff spent time with me discussing my condition and making plans for follow up care. She is very professional, but able to converse well with me.
I could not be more pleased and satisfied
Dr. Dillhoff is an excellent physician. I will always recommend her & her team to anyone who needs that type of care. I am thankful that Dr. Box recommended her & her team.
Excellent care
She was amazing, patient and thorough
Very thorough, very kind
Would recommend Dr. Dilhoff to anyone. She's great.
Dr Dillhoff is our kind of doctor, personable, engaged, willing to answer questions and show personal attention!
Good
I think Dr. Dillhoff is an excellent doctor.
Good
Dr Dilhoff is an amazing physician- I truly trust her judgment and care.
Everyone I saw was kind, need not seemed rushed and explained things thoroughly
Dr dillhoff is the greatest surgon I have ever known. My degree is in health care management. Her teams are the greatest! Petsonal attention to her patients is the best I have known!
Dr. Mary Dilhoff is an excellent specialist. She listens and answers all questions. Her explanation of my tests and condition is clear and concise. I trust her skill and judgment.
Dr. Dillhoff is phenomenal, love her and how she treats me during my appointments. She truly cares.
She celebrated with me six years Cancer free!
Excellent treatment and very knowledgeable.
Physician was extremely detailed in reviewing my tests. And very compassionate in discussing our plan for further treatment. I appreciated her for giving me peace of mind after a scary diagnosis.
Dr Dillhoff is EXCEPTIONAL
Appreciate the time spent exposing everything and answering questions
Best outcome for me, but rather see my team at a bar so I can buy them a round (after hours!!) Merry Christmas!!
Seemed very knowledgeable of my situation and the process of care for it.
Dr. Clinton, Box, Dillhoff and Martin are true blessings. These drs. are truly Angels of Mercy, sharing their gifts of skill and knowledge.
Everyone excellent and professional.
The dr. was very kind and answered all our questions (my family has a lot) she never rushed with us. She explained future steps of treatments.
Dr. Dillhoff is an exceptional physician
Very impressed with the doctor. Explained the procedure so I understood.
Dr. Dillhoff is excellent with providing info for the patient. She discusses every concern, shows the actual scans, etc.
Dr. Dillhoff have a very clear explanation about checking some old images showing the area in question and why she determined there is no cancerous involvement.
Very good.
Dr Dilhoff is an amazing physician - I trust her with my care.